NRG-GY023: Durvalumab, Olaparib, and Cediranib vs Chemotherapy in Platinum-Resistant Ovarian Cancer with Prior Bevacizumab Last updated on Jun 8, 2026 Previous One Hundred Posts: GYOEDU Website Updates Next Publications Update # 100
